Correlation between the immune response to COVID-19 vaccines and the constitutions of traditional Chinese medicine.

Correlation between the immune response to COVID-19 vaccines and the constitutions of traditional Chinese medicine.

Publication date: Dec 01, 2025

Traditional Chinese Medicine (TCM) classifies individuals into constitution types that may influence physiological responses. SARS-CoV-2 vaccines induce spike-specific antibodies and activate B and T cells, including memory subsets. This study investigates whether TCM constitution types are associated with immune responses and adverse events following COVID-19 vaccination. From March 2021 to December 2023, 78 adults received two doses of the COVID-19 vaccine, including AstraZeneca, Moderna, MVC-COV1901, and Pfizer-BioNTech. PBMCs were collected before and after vaccination. Immune parameters-cytokines, antibody titers, dendritic cells (DCs), T cells, B cells, and memory T cell subsets-were measured. TCM constitution scores were determined using the Constitution in Chinese Medicine Questionnaire (CCMQ) before vaccination. Adverse reactions were recorded through structured surveys, and correlations between constitution scores and adverse events were analyzed using the Pearson correlation. Pre-vaccination TNF-α was negatively correlated with the gentleness constitution and positively with the qi-deficiency. DCs increased post-vaccination in individuals with qi-deficiency, phlegm-dampness, qi-depression, yin-deficiency, dampness-heat, and special diathesis constitutions. T cell proportions increased in yin-deficiency, dampness-heat, and special diathesis groups. Dampness-heat scores were negatively correlated with central memory T cell (Tcm) induction. No significant correlations were found between constitution types and antibody levels or neutralization. Adverse reactions were more frequent in individuals with phlegm-dampness, qi-depression, and blood-stasis constitutions, and less frequent in those with a gentleness constitution. TCM constitutions correlate with cellular immune responses and adverse reaction profiles, but not antibody production, after COVID-19 vaccination. This supports integrating TCM constitution frameworks into personalized vaccine prediction.

Open Access PDF

Concepts Keywords
Astrazeneca Adult
Chinese adverse reaction
December Aged
Vaccines Antibodies, Viral
Antibodies, Viral
COVID-19
COVID-19 vaccine
COVID-19 Vaccines
COVID-19 Vaccines
Cytokines
Cytokines
Dendritic Cells
Female
Humans
Male
Medicine, Chinese Traditional
memory T-cell
Middle Aged
SARS-CoV-2
spike antibody
Young Adult

Semantics

Type Source Name
disease IDO immune response
disease MESH COVID-19
drug DRUGBANK Cycloserine
disease IDO cell
disease MESH depression
disease IDO blood
drug DRUGBANK Coenzyme M
disease MESH yin deficiency
disease IDO history
disease MESH pneumonia
disease IDO host
disease IDO protein
pathway REACTOME Reproduction
disease IDO production
drug DRUGBANK Tretamine
disease IDO site
disease MESH joint pain
disease MESH yang deficiency
disease IDO susceptibility
disease MESH sweating
disease MESH infections
disease MESH edema
disease MESH acne
disease MESH hypersensitivity
pathway REACTOME Immune System
disease MESH obesity
disease IDO infection
disease IDO pathogen
disease IDO process
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Etoperidone
drug DRUGBANK Flunarizine
drug DRUGBANK Acetate ion
disease IDO assay
drug DRUGBANK Trestolone
drug DRUGBANK Sodium lauryl sulfate
disease MESH hypertension
disease MESH hyperlipidemia
disease MESH hyperglycemia
disease IDO algorithm
drug DRUGBANK Aspartame
drug DRUGBANK Esomeprazole
disease MESH dysbiosis
disease MESH anxiety
disease MESH sleep quality
drug DRUGBANK (S)-Des-Me-Ampa
pathway KEGG Allograft rejection
drug DRUGBANK Aluminum hydroxide
disease MESH long COVID
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Phenylpropanolamine
drug DRUGBANK Lincomycin
disease MESH Asthma
pathway KEGG Asthma
drug DRUGBANK Guanosine
drug DRUGBANK Reserpine
disease MESH overweight
disease MESH underweight
drug DRUGBANK Silver
disease MESH syndrome
disease MESH ulcerative colitis
disease MESH inflammation
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH Influenza

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *